Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Shares Issued (2016 - 2025)

Macrogenics (MGNX) has disclosed Shares Issued for 14 consecutive years, with $63000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 101.92% to $63000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $129000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $129000.0 for FY2025, N/A changed from the prior year.
  • Shares Issued for Q4 2025 was $63000.0 at Macrogenics, down from $66000.0 in the prior quarter.
  • The five-year high for Shares Issued was $112.1 million in Q4 2021, with the low at -$92.5 million in Q3 2021.
  • Average Shares Issued over 5 years is $9.2 million, with a median of $66000.0 recorded in 2025.
  • The sharpest move saw Shares Issued surged 295089.47% in 2021, then plummeted 5100.0% in 2024.
  • Over 5 years, Shares Issued stood at $112.1 million in 2021, then tumbled by 99.49% to $574000.0 in 2022, then crashed by 110.98% to -$63000.0 in 2023, then tumbled by 5100.0% to -$3.3 million in 2024, then surged by 101.92% to $63000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $63000.0, $66000.0, and -$3.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.